NIAGARA FALLS, N.Y.--(BUSINESS WIRE)--Cabbacis (the 'Company'), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that it has purchased the www.iBlend.com domain to feature the iBlend™ brand.

纽约州尼亚加拉大瀑布（商业新闻短讯）--美国联邦特许烟草产品制造商和植物生物技术公司Cabbacis（以下简称“公司”）今天宣布，它已购买了www.iBlend.com域名，以提供iBlend™ 品牌。

The iBlend.com domain has been anonymously pursued by Cabbacis for about one year and the Company recently purchased the domain for $18,000. Tobacco products being developed under the iBlend™ brand comprise predominately of reduced nicotine tobacco and are blended with hemp, and the iBlend.com domain will be utilized for these blended tobacco products..

Cabbacis匿名使用iBlend.com域名已有一年左右的时间，该公司最近以18000美元的价格购买了该域名。iBlend下正在开发的烟草产品™ 该品牌主要由减少尼古丁的烟草组成，并与大麻混合，iBlend.com域名将用于这些混合烟草产品。。

'The iBlend trademark has been filed and registered worldwide, and the acquisition of the iBlend.com domain greatly compliments our brand and international trademark coverage,' stated Joseph Pandolfino, the Company’s CEO. Cabbacis had previously acquired various other 'iBlend' domains such as iBlend.net and iBlend.org..

该公司首席执行官约瑟夫·潘多尔菲诺（JosephPandolfino）表示：“iBlend商标已在全球范围内备案和注册，收购iBlend.com域名极大地提升了我们的品牌和国际商标覆盖率。”。Cabbacis之前收购了其他各种“iBlend”域，例如iBlend.net和iBlend.org。。

About Cabbacis

关于Cabbacis

Cabbacis is a tobacco product manufacturer and plant biotechnology company committed to developing and commercializing reduced nicotine cigarettes and vaporizer pods. Both types of products in development are predominately tobacco and include hemp. The Company stands ready to also move forward with reduced nicotine tobacco cigarettes without hemp..

Cabbacis是一家烟草产品制造商和植物生物技术公司，致力于开发和商业化减少尼古丁的香烟和汽化器。正在开发的两种产品主要是烟草，包括大麻。该公司还准备推出不含大麻的低尼古丁烟草香烟。。

Reduced nicotine cigarettes without hemp have been evaluated in dozens of independent studies and contain about 95 percent less nicotine than conventional cigarettes. Results demonstrate that subjects smoked fewer cigarettes per day, reduced their nicotine dependence and exposure, doubled their quit attempts, and/or increased their number of smoke-free days.

数十项独立研究评估了不含大麻的低尼古丁香烟，其尼古丁含量比传统香烟低约95%。结果表明，受试者每天吸烟量减少，尼古丁依赖和暴露减少，戒烟次数增加一倍，和/或无烟天数增加。

The Company believes including hemp flower into reduced nicotine cigarettes improves sensory characteristics and the Company expects effectiveness to also improve due to the presence of non-THC cannabinoids..

该公司认为，在减少尼古丁的香烟中加入大麻花可以改善感官特性，并且由于非THC大麻素的存在，该公司预计效果也会提高。。

The Company’s worldwide patent portfolio includes 31 issued patents and various pending patent applications across the United States, Europe, China, Japan, South Korea, Canada, Australia, New Zealand, Mexico, Brazil and other countries — where approximately two-thirds of the world’s smokers reside. The Company holds 6 U.S.

该公司的全球专利组合包括美国、欧洲、中国、日本、韩国、加拿大、澳大利亚、新西兰、墨西哥、巴西和其他国家（约三分之二的世界吸烟者居住在这些国家）的31项已发布专利和各种待决专利申请。该公司拥有6家美国公司。

patents. Cabbacis Inc wholly owns Cabbacis LLC..

专利。Cabbacis Inc全资拥有Cabbacis LLC。。

To learn more about Cabbacis, please visit www.cabbacis.com.

要了解更多有关Cabbacis的信息，请访问www.Cabbacis.com。

Cautionary Note Regarding Forward-Looking Statements

关于前瞻性声明的警示说明

This press release includes forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical or current facts made in this document are forward-looking. We identify forward-looking statements in this document by using words or phrases such as 'anticipate,' 'believe,' 'consider,' 'continue,' 'could,' 'estimate,' 'expect,' 'foresee,' 'intend,' 'likely,' 'may,' 'objective,' 'plan,' 'potential,' 'plan,' 'predict,' 'project,' 'seek,' 'should,' 'will' and similar words or phrases and their negatives.

本新闻稿包括《联邦证券法》所指的前瞻性声明。本文件中除历史或当前事实陈述外的所有陈述均为前瞻性陈述。我们通过使用诸如“预期”、“相信”、“考虑”、“继续”、“可能”、“估计”、“预期”、“预见”、“打算”、“可能”、“可能”、“目标”、“计划”、“潜力”、“计划”、“预测”、“项目”、“寻求”、“应该”、“将要”等词语或短语以及类似的词语或短语及其否定词来识别本文件中的前瞻性陈述。

Forward-looking statements reflect our current expectations and are inherently uncertain. Actual outcomes or results could differ materially for a variety of reasons. Factors that could cause actual results to differ materially are described in 'Risk Factors' in our Regulation A Offering Circular filed with the SEC and, when filed, our Annual Report on Form 1-K for the period ended December 31, 2023.

前瞻性陈述反映了我们目前的期望，并且本质上是不确定的。由于各种原因，实际结果或结果可能存在重大差异。可能导致实际结果产生重大差异的因素在提交给美国证券交易委员会的监管A发行通函中的“风险因素”中进行了描述，并且在提交时，我们以表格1-K的形式提交了截至2023年12月31日的年度报告。

We undertake no responsibility to publicly update or revise any forward-looking statement except as required by applicable law..

除适用法律要求外，我们不承担公开更新或修改任何前瞻性声明的责任。。